Intestinal Microbiota and Sclerosis Lateral Amyotrophic
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng por |
Título da fonte: | Revista Ciências em Saúde |
Texto Completo: | https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223 |
Resumo: | The human gastrointestinal tract contains numerous microorganisms. This intestinal microbiota (IM) has a mutualistic relationship with the human organism, and it plays a fundamental role in regulating metabolic, endocrine, and immunological functions. Intestinal dysbiosis is associated with phenotypes of many chronic and inflammatory diseases. This association is explained by the functions of the IM and the existing bi-directional communication of the microbiota-intestine-brain axis. Studies have uncovered new evidence between the IM and neurodegenerative diseases recently, including amyotrophic lateral sclerosis (ALS). Given this, the present narrative review discusses didactically about IM, its functions, its relationship with the neuroimmune-endocrine system, and its association with neurodegenerative diseases, with emphasis on ALS. |
id |
RCS_4cb0c3a78cbe75da416bb181f0bdb930 |
---|---|
oai_identifier_str |
oai:ojs.portalrcs.hcitajuba.org.br:article/1223 |
network_acronym_str |
RCS |
network_name_str |
Revista Ciências em Saúde |
repository_id_str |
|
spelling |
Intestinal Microbiota and Sclerosis Lateral AmyotrophicMicrobiota Intestinal e Esclerose Lateral Amiotróficaamyotrophic lateral sclerosisdysbiosisgut microbiotaneurodegenerative diseasesdisbiosedoenças neurodegenerativasesclerose lateral amiotróficamicrobiota intestinalThe human gastrointestinal tract contains numerous microorganisms. This intestinal microbiota (IM) has a mutualistic relationship with the human organism, and it plays a fundamental role in regulating metabolic, endocrine, and immunological functions. Intestinal dysbiosis is associated with phenotypes of many chronic and inflammatory diseases. This association is explained by the functions of the IM and the existing bi-directional communication of the microbiota-intestine-brain axis. Studies have uncovered new evidence between the IM and neurodegenerative diseases recently, including amyotrophic lateral sclerosis (ALS). Given this, the present narrative review discusses didactically about IM, its functions, its relationship with the neuroimmune-endocrine system, and its association with neurodegenerative diseases, with emphasis on ALS.O trato gastrintestinal humano é povoado por uma grande quantidade de microrganismos. Essa microbiota intestinal (MI) tem uma relação de mutualismo com o organismo humano e desempenha papel fundamental na regulação de funções metabólicas, endócrinas e imunológicas. A disbiose intestinal está associada a fenótipos de várias doenças crônicas e inflamatórias. Essa associação é explicada pelas funções da MI e a existente comunicação bidirecional do eixo microbiota-intestino-cérebro. Nos últimos anos, estudos têm mostrado novas evidências entre a MI e as doenças neurodegenerativas, incluindo a esclerose lateral amiotrófica (ELA). Diante disso, essa revisão narrativa discorre de forma didática sobre a MI, suas funções, sua relação com o sistema neuro-imuno-endócrino e sua associação com as doenças neurodegenerativas, com ênfase na ELA.AISI/HCI2022-03-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer reviewedAvaliado pelos parestextoinfo:eu-repo/semantics/otherapplication/pdfapplication/pdfhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/122310.21876/rcshci.v12i1.1223Revista Ciências em Saúde; v. 12 n. 1 (2022): Janeiro a Março de 2022; 3-13Health Sciences Journal; Vol 12 No 1 (2022): January to March 2022; 3-132236-378510.21876/rcshci.v12i1reponame:Revista Ciências em Saúdeinstname:Hospital de Clínicas de Itajubáinstacron:HCIengporhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223/789https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223/790Copyright (c) 2022 Revista Ciências em Saúdehttps://creativecommons.org/licenses/by-nc-sa/4.0info:eu-repo/semantics/openAccessVilar, Mariana Dantas de CarvalhoVale, Sancha Helena de LimaRosado, Eliane LopesDourado Júnior, Mário Emílio TeixeiraBrandão-Neto, JoséLeite-Lais, Lúcia2022-05-16T00:33:17Zoai:ojs.portalrcs.hcitajuba.org.br:article/1223Revistahttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zeroPUBhttps://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/oaircs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br2236-37852236-3785opendoar:2022-05-16T00:33:17Revista Ciências em Saúde - Hospital de Clínicas de Itajubáfalse |
dc.title.none.fl_str_mv |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic Microbiota Intestinal e Esclerose Lateral Amiotrófica |
title |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic |
spellingShingle |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic Vilar, Mariana Dantas de Carvalho amyotrophic lateral sclerosis dysbiosis gut microbiota neurodegenerative diseases disbiose doenças neurodegenerativas esclerose lateral amiotrófica microbiota intestinal |
title_short |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic |
title_full |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic |
title_fullStr |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic |
title_full_unstemmed |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic |
title_sort |
Intestinal Microbiota and Sclerosis Lateral Amyotrophic |
author |
Vilar, Mariana Dantas de Carvalho |
author_facet |
Vilar, Mariana Dantas de Carvalho Vale, Sancha Helena de Lima Rosado, Eliane Lopes Dourado Júnior, Mário Emílio Teixeira Brandão-Neto, José Leite-Lais, Lúcia |
author_role |
author |
author2 |
Vale, Sancha Helena de Lima Rosado, Eliane Lopes Dourado Júnior, Mário Emílio Teixeira Brandão-Neto, José Leite-Lais, Lúcia |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Vilar, Mariana Dantas de Carvalho Vale, Sancha Helena de Lima Rosado, Eliane Lopes Dourado Júnior, Mário Emílio Teixeira Brandão-Neto, José Leite-Lais, Lúcia |
dc.subject.por.fl_str_mv |
amyotrophic lateral sclerosis dysbiosis gut microbiota neurodegenerative diseases disbiose doenças neurodegenerativas esclerose lateral amiotrófica microbiota intestinal |
topic |
amyotrophic lateral sclerosis dysbiosis gut microbiota neurodegenerative diseases disbiose doenças neurodegenerativas esclerose lateral amiotrófica microbiota intestinal |
description |
The human gastrointestinal tract contains numerous microorganisms. This intestinal microbiota (IM) has a mutualistic relationship with the human organism, and it plays a fundamental role in regulating metabolic, endocrine, and immunological functions. Intestinal dysbiosis is associated with phenotypes of many chronic and inflammatory diseases. This association is explained by the functions of the IM and the existing bi-directional communication of the microbiota-intestine-brain axis. Studies have uncovered new evidence between the IM and neurodegenerative diseases recently, including amyotrophic lateral sclerosis (ALS). Given this, the present narrative review discusses didactically about IM, its functions, its relationship with the neuroimmune-endocrine system, and its association with neurodegenerative diseases, with emphasis on ALS. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-03-29 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer reviewed Avaliado pelos pares texto info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223 10.21876/rcshci.v12i1.1223 |
url |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223 |
identifier_str_mv |
10.21876/rcshci.v12i1.1223 |
dc.language.iso.fl_str_mv |
eng por |
language |
eng por |
dc.relation.none.fl_str_mv |
https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223/789 https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1223/790 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Revista Ciências em Saúde https://creativecommons.org/licenses/by-nc-sa/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Revista Ciências em Saúde https://creativecommons.org/licenses/by-nc-sa/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
AISI/HCI |
publisher.none.fl_str_mv |
AISI/HCI |
dc.source.none.fl_str_mv |
Revista Ciências em Saúde; v. 12 n. 1 (2022): Janeiro a Março de 2022; 3-13 Health Sciences Journal; Vol 12 No 1 (2022): January to March 2022; 3-13 2236-3785 10.21876/rcshci.v12i1 reponame:Revista Ciências em Saúde instname:Hospital de Clínicas de Itajubá instacron:HCI |
instname_str |
Hospital de Clínicas de Itajubá |
instacron_str |
HCI |
institution |
HCI |
reponame_str |
Revista Ciências em Saúde |
collection |
Revista Ciências em Saúde |
repository.name.fl_str_mv |
Revista Ciências em Saúde - Hospital de Clínicas de Itajubá |
repository.mail.fl_str_mv |
rcs@hcitajuba.org.br||rcsfmit@medicinaitajuba.com.br |
_version_ |
1797068963295789056 |